What is the CVSS score of CVE-2023-41088?

CVE-2023-41088 has a CVSS 3.1 base score of 6.5 (Medium). CVSS vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N. EPSS exploitation probability: 0.2%.

Dexgate CVE-2023-41088

MEDIUM

Cleartext Transmission of Sensitive Information (CWE-319)

2023-10-19 ics-cert@hq.dhs.gov

Information Disclosure Dexgate

6.5

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

6.5 MEDIUM

AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N

Attack Vector

Network

Attack Complexity

Low

Privileges Required

None

User Interaction

Required

Scope

Unchanged

Confidentiality

High

Integrity

None

Availability

None

Lifecycle Timeline

CVE Published

Oct 19, 2023 - 19:15 nvd

MEDIUM 6.5

DescriptionNVD

The affected product is vulnerable to a cleartext transmission of sensitive information vulnerability, which may allow an attacker with access to the network, where clients have access to the DexGate server, could capture traffic. The attacker can later us the information within it to access the application.

AnalysisAI

The affected product is vulnerable to a cleartext transmission of sensitive information vulnerability, which may allow an attacker with access to the network, where clients have access to the DexGate. Rated medium severity (CVSS 6.5), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.

Technical ContextAI

This vulnerability is classified under CWE-319. The affected product is vulnerable to a cleartext transmission of sensitive information vulnerability, which may allow an attacker with access to the network, where clients have access to the DexGate server, could capture traffic. The attacker can later us the information within it to access the application. Affected products include: Dexma Dexgate.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Apply vendor patches when available. Implement network segmentation and monitoring as interim mitigations.